Having that high-deductible health plan might kill you, literally

Recent research published in JAMA Network Open reveals alarming insights about high-deductible health plans (HDHPs), particularly for cancer patients. The study indicates that individuals facing substantial out-of-pocket expenses alongside a cancer diagnosis experience significantly worse overall and cancer-specific survival rates compared to those enrolled in more conventional insurance plans. As healthcare costs escalate, many Americans are opting for insurance plans with higher deductibles, hoping to alleviate financial burdens. However, this choice can lead to dire consequences, especially for those diagnosed with serious illnesses like cancer. The findings underscore the difficult decisions that individuals must navigate as they weigh the costs and benefits of their health insurance options. The situation is particularly urgent for those utilizing insurance plans from the Affordable Care Act (ACA) marketplace. This year, premiums for ACA plans have soared following Congress's failure to renew essential tax credits. As a result, the average monthly premium for these plans has more than doubled, leading to a notable decline in enrollment numbers for 2026. The data suggests that those who are continuing to enroll are increasingly selecting bronze plans, which are characterized by their high deductibles. In this study, researchers defined HDHPs as plans requiring deductibles of at least $1,200 to $1,350 for individuals or $2,400 to $2,700 for families during the 2011 to 2018 period. For perspective, the average individual deductible for a bronze plan in 2026 is projected to reach approximately $7,500, according to the Kaiser Family Foundation. The implications of high out-of-pocket costs extend beyond financial strain; they can lead patients to postpone or forgo necessary healthcare services. This trend, highlighted in previous research, raises critical concerns about access to timely medical care, particularly for those battling cancer. The study, led by Justin Barnes at the Mayo Clinic in Rochester, Minnesota, aims to shed light on how these insurance plans directly impact survival rates for those in desperate need of treatment.